Trademark Overview
On Saturday, September 16, 2023, a trademark application was filed for ONCOLIQUID with the United States Patent and Trademark Office. The USPTO has given the ONCOLIQUID trademark a serial number of 98183326. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, June 18, 2024. This trademark is owned by Genomic Health, Inc.. The ONCOLIQUID trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:
Medical testing for diagnostic and prognostic purposes and therapy selection in the field of cancer and disease classification; Medical testing for diagnostic and treatment purposes in the field of cancer research and disease classification; Providing medical information to medical professionals, namely, oncologists and treating physicians for cancer patients, in the form of reports in the field of cancer diagnostics and prognostics; Medical testing services, namely, genetic testing and next generation sequencing test for diagnosis and treatment of cancer